142 related articles for article (PubMed ID: 10588060)
21. C-erb B2 oncoprotein expression. Correlation with the Ki-67 labeling index and AgNOR counts in breast carcinoma on fine needle aspiration cytology.
Sinha SK; Singh UR; Bhatia A
Acta Cytol; 1996; 40(6):1217-20. PubMed ID: 8960031
[TBL] [Abstract][Full Text] [Related]
22. AgNOR evaluation by image processing methods. Staining modifications and results in 126 invasive ductal breast carcinomas.
Giménez-Mas JA; Gallego-Calvo P; Sanz-Moncasi P; Ríos-Mitchell J; Valero I; Sanz-Anquela M; Burriel J; Bavai A
Anal Quant Cytol Histol; 1996 Feb; 18(1):9-18. PubMed ID: 8851103
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of proliferative activity of ovarian carcinoma as revealed by PCNA and AgNOR analyses.
Ghazizadeh M; Sasaki Y; Araki T; Konishi H; Aihara K
Am J Clin Pathol; 1997 Apr; 107(4):451-8. PubMed ID: 9124214
[TBL] [Abstract][Full Text] [Related]
24. Standardized in situ AgNOR analysis in breast pathology: diagnostic and cell kinetic implications.
Bànkfalvi A; Ofner D; Schmid KW; Schmitz KJ; Breukelmann D; Krech R; Böcker W
Pathol Res Pract; 1999; 195(4):219-29. PubMed ID: 10337659
[TBL] [Abstract][Full Text] [Related]
25. The prognostic significance of AgNOR counts in lymph node deposits of breast carcinomas.
Sivridis E; Anastasiadis P; Diamantopoulos P; Agnantis JN
Pathol Res Pract; 1993 Sep; 189(8):877-81. PubMed ID: 8302710
[TBL] [Abstract][Full Text] [Related]
26. Morphometric determination of AgNORs in breast carcinoma. Correlation with flow cytometry and proliferating cell nuclear antigen.
Bellotti M; Elsner B; Kahn A; Bezodnick L; Pisilli L; Greco P
Anal Quant Cytol Histol; 1997 Apr; 19(2):139-44. PubMed ID: 9113306
[TBL] [Abstract][Full Text] [Related]
27. Proliferative activity is a significant prognostic factor in male breast carcinoma.
Pich A; Margaria E; Chiusa L
Am J Pathol; 1994 Aug; 145(2):481-9. PubMed ID: 7519830
[TBL] [Abstract][Full Text] [Related]
28. AgNOR counts have no prognostic value in breast cancer.
Toikkanen S; Joensuu H
J Pathol; 1993 Feb; 169(2):251-4. PubMed ID: 8445490
[TBL] [Abstract][Full Text] [Related]
29. Assessment of the expression of p53, MIB-1 (Ki-67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct.
Suto T; Sugai T; Nakamura S; Funato O; Nitta H; Sasaki R; Kanno S; Saito K
Cancer; 1998 Jan; 82(1):86-95. PubMed ID: 9428483
[TBL] [Abstract][Full Text] [Related]
30. p120 and AgNOR nucleolar protein expression: a comparison with nuclear proliferation markers in oral pathology.
Migaldi M; Criscuolo M; Zunarelli E; Lo Bianco L; Martinelli AM; Barbolini G
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 Feb; 85(2):189-96. PubMed ID: 9503455
[TBL] [Abstract][Full Text] [Related]
31. [Silver-stained Nucleolar Organizer Regions (AgNOR)].
Derenzini M; Trerè D
Pathologica; 2001 Apr; 93(2):99-105. PubMed ID: 11428299
[TBL] [Abstract][Full Text] [Related]
32. The quantity of nucleolar proteins nucleolin and protein B23 is related to cell doubling time in human cancer cells.
Derenzini M; Sirri V; Trerè D; Ochs RL
Lab Invest; 1995 Oct; 73(4):497-502. PubMed ID: 7474921
[TBL] [Abstract][Full Text] [Related]
33. Correlation of two AgNOR counts with Ki-67 labeling index: a study in fine-needle aspirates of lymphoproliferative disorders and breast carcinoma.
Mourad WA; Sneige N; Katz RL; Ordóñez NG
Diagn Cytopathol; 1994; 10(2):113-9. PubMed ID: 8187588
[TBL] [Abstract][Full Text] [Related]
34. Influence of fixation and preparation on the AgNOR distribution in routinely processed breast cancer specimens.
Biesterfeld S; Ruoss E; Hufnagl P; Martin H
Zentralbl Pathol; 1994 Mar; 140(1):41-8. PubMed ID: 7515672
[TBL] [Abstract][Full Text] [Related]
35. Technique and feasibility of a dual staining method for estrogen receptors and AgNORs.
Günther L; Hufnagl P
Anal Cell Pathol; 2000; 20(4):151-4. PubMed ID: 11205317
[TBL] [Abstract][Full Text] [Related]
36. Correlation between silver-stained nucleolar organizer region area and cell cycle time.
Canet V; Montmasson MP; Usson Y; Giroud F; Brugal G
Cytometry; 2001 Feb; 43(2):110-6. PubMed ID: 11169575
[TBL] [Abstract][Full Text] [Related]
37. AgNOR count in resting cells (resting NOR) is a new prognostic marker in invasive bladder tumor.
Tomobe M; Shimazui T; Uchida K; Akaza H
Anal Cell Pathol; 2001; 22(4):193-9. PubMed ID: 11564895
[TBL] [Abstract][Full Text] [Related]
38. Standardized AgNOR analysis of the invasive tumour front in oral squamous cell carcinomas.
Piffkò J; Bànkfalvi A; Ofner D; Rasch D; Joos U; Schmid KW
J Pathol; 1997 Aug; 182(4):450-6. PubMed ID: 9306967
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of argyrophylic nucleolar organiser regions (AgNORs) in breast lesions.
Simha M; Menon M; Doctor V
Indian J Cancer; 1996 Jun; 33(2):76-85. PubMed ID: 8979469
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of standardized AgNOR analysis in early and advanced gastric carcinomas.
Giuffrè G; Caruso RA; Barresi G; Tuccari G
Virchows Arch; 1998 Sep; 433(3):261-6. PubMed ID: 9769130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]